ScienceStanford reportedly built a virtual biotech company with 37,000 AI agents
A post claims the agents analyzed about 50,000 clinical trials in under a week, uncovering biological signals linked to better drug success.
TLDR
A post describes a Stanford-built virtual biotech company with 37,000 AI scientist agents, claiming they analyzed about 50,000 clinical trials in under a week. It also says the agents independently designed a B7-H3 lung cancer therapy strategy that a pharmaceutical company later developed separately and advanced into human testing.
Combined views
24K
1 Source, first seen 4d ago
Stanford reportedly built a virtual biotech company with 37,000 AI agents
A post claims the agents analyzed about 50,000 clinical trials in under a week, uncovering biological signals linked to better drug success.
TLDR
A post describes a Stanford-built virtual biotech company with 37,000 AI scientist agents, claiming they analyzed about 50,000 clinical trials in under a week. It also says the agents independently designed a B7-H3 lung cancer therapy strategy that a pharmaceutical company later developed separately and advanced into human testing.